{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T22:48:32Z","timestamp":1789253312328,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"The Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP20K09422"],"award-info":[{"award-number":["JP20K09422"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"The Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["JP20K18052"],"award-info":[{"award-number":["JP20K18052"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10549-021-06243-2","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T13:28:57Z","timestamp":1620048537000},"page":"649-659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Machine learning-based image analysis for accelerating the diagnosis of complicated preneoplastic and neoplastic ductal lesions in breast biopsy tissues"],"prefix":"10.1007","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2155-2379","authenticated-orcid":false,"given":"Shinya","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihide","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kae","family":"Kawachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Washimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Ohkubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Yokose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinari","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Ohtori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,1]]},"reference":[{"issue":"9801","key":"6243_CR1","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/S0140-6736(11)61351-2","volume":"378","author":"MH Forouzanfar","year":"2011","unstructured":"Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, Naghavi M (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 378(9801):1461\u20131484. https:\/\/doi.org\/10.1016\/S0140-6736(11)61351-2","journal-title":"Lancet"},{"issue":"1","key":"6243_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics. CA Cancer J Clin 70(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21590","journal-title":"CA Cancer J Clin"},{"issue":"22","key":"6243_CR3","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1200\/JCO.2015.66.1595","volume":"34","author":"MN Dickler","year":"2016","unstructured":"Dickler MN, Barry WT, Cirrincione CT, Ellis MJ, Moynahan ME, Innocenti F, Hurria A, Rugo HS, Lake DE, Hahn O, Schneider BP, Tripathy D, Carey LA, Winer EP, Hudis CA (2016) Phase III trial evaluating letrozole as first-line endocrine therapy with or without bevacizumab for the treatment of postmenopausal women with hormone receptor-positive advanced-stage breast cancer: CALGB 40503 (Alliance). J Clin Oncol 34(22):2602\u20132609. https:\/\/doi.org\/10.1200\/JCO.2015.66.1595","journal-title":"J Clin Oncol"},{"key":"6243_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejca.2019.06.002","volume":"117","author":"M Martin","year":"2019","unstructured":"Martin M, Loibl S, Hyslop T, De la Haba-Rodriguez J, Aktas B, Cirrincione CT, Mehta K, Barry WT, Morales S, Carey LA, Garcia-Saenz JA, Partridge A, Martinez-Janez N, Hahn O, Winer E, Guerrero-Zotano A, Hudis C, Casas M, Rodriguez-Martin C, Furlanetto J, Carrasco E, Dickler MN, Group GSBC, Gbg Alliance for Clinical Trials in O (2019) Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM\/2006-11_GBG51) and CALGB 40503 (Alliance) trials. Eur J Cancer 117:91\u201398. https:\/\/doi.org\/10.1016\/j.ejca.2019.06.002","journal-title":"Eur J Cancer"},{"issue":"36","key":"6243_CR5","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1200\/JCO.18.02217","volume":"37","author":"LJ Howie","year":"2019","unstructured":"Howie LJ, Singh H, Bloomquist E, Wedam S, Amiri-Kordestani L, Tang S, Sridhara R, Sanchez J, Prowell TM, Kluetz PG, King-Kallimanis BL, Gao JJ, Ibrahim A, Goldberg KB, Theoret M, Pazdur R, Beaver JA (2019) Outcomes of older women with hormone receptor-positive, human epidermal growth factor receptor-negative metastatic breast cancer treated with a CDK4\/6 inhibitor and an aromatase inhibitor: an FDA pooled analysis. J Clin Oncol 37(36):3475\u20133483. https:\/\/doi.org\/10.1200\/JCO.18.02217","journal-title":"J Clin Oncol"},{"issue":"2","key":"6243_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/path.2808","volume":"223","author":"A Bombonati","year":"2011","unstructured":"Bombonati A, Sgroi DC (2011) The molecular pathology of breast cancer progression. J Pathol 223(2):307\u2013317. https:\/\/doi.org\/10.1002\/path.2808","journal-title":"J Pathol"},{"key":"6243_CR7","volume-title":"WHO classification of tumours. Breast tumours. World Health Organization classification of tumours","author":"WHO Classification of Tumours Editorial Board","year":"2019","unstructured":"WHO Classification of Tumours Editorial Board, International Agency for Research on Cancer, World Health Organization (2019) WHO classification of tumours. Breast tumours. World Health Organization classification of tumours, 5th edn. International Agency for Research on Cancer, Lyon","edition":"5"},{"issue":"2","key":"6243_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/jcp.21858","volume":"221","author":"RM Tomasino","year":"2009","unstructured":"Tomasino RM, Morello V, Gullo A, Pompei G, Agnese V, Russo A, Rinaldi G (2009) Assessment of \u201cgrading\u201d with Ki-67 and c-kit immunohistochemical expressions may be a helpful tool in management of patients with flat epithelial atypia (FEA) and columnar cell lesions (CCLs) on core breast biopsy. J Cell Physiol 221(2):343\u2013349. https:\/\/doi.org\/10.1002\/jcp.21858","journal-title":"J Cell Physiol"},{"issue":"5","key":"6243_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00428-017-2073-7","volume":"470","author":"W Boecker","year":"2017","unstructured":"Boecker W, Stenman G, Schroeder T, Schumacher U, Loening T, Stahnke L, Lohnert C, Siering RM, Kuper A, Samoilova V, Tiemann M, Korsching E, Buchwalow I (2017) Multicolor immunofluorescence reveals that p63- and\/or K5-positive progenitor cells contribute to normal breast epithelium and usual ductal hyperplasia but not to low-grade intraepithelial neoplasia of the breast. Virchows Arch 470(5):493\u2013504. https:\/\/doi.org\/10.1007\/s00428-017-2073-7","journal-title":"Virchows Arch"},{"issue":"6","key":"6243_CR10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00428-006-0245-y","volume":"449","author":"M Ghofrani","year":"2006","unstructured":"Ghofrani M, Tapia B, Tavassoli FA (2006) Discrepancies in the diagnosis of intraductal proliferative lesions of the breast and its management implications: results of a multinational survey. Virchows Arch 449(6):609\u2013616. https:\/\/doi.org\/10.1007\/s00428-006-0245-y","journal-title":"Virchows Arch"},{"issue":"4","key":"6243_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000319624","volume":"5","author":"HP Sinn","year":"2010","unstructured":"Sinn HP, Elsawaf Z, Helmchen B, Aulmann S (2010) Early breast cancer precursor lesions: lessons learned from molecular and clinical studies. Breast Care 5(4):218\u2013226. https:\/\/doi.org\/10.1159\/000319624","journal-title":"Breast Care"},{"issue":"4","key":"6243_CR12","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/path.972","volume":"195","author":"FJ Leong","year":"2001","unstructured":"Leong FJ, McGee JO (2001) Automated complete slide digitization: a medium for simultaneous viewing by multiple pathologists. J Pathol 195(4):508\u2013514. https:\/\/doi.org\/10.1002\/path.972","journal-title":"J Pathol"},{"issue":"3","key":"6243_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.humpath.2005.11.005","volume":"37","author":"J Ho","year":"2006","unstructured":"Ho J, Parwani AV, Jukic DM, Yagi Y, Anthony L, Gilbertson JR (2006) Use of whole slide imaging in surgical pathology quality assurance: design and pilot validation studies. Hum Pathol 37(3):322\u2013331. https:\/\/doi.org\/10.1016\/j.humpath.2005.11.005","journal-title":"Hum Pathol"},{"key":"6243_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1472-6890-6-4","volume":"6","author":"JR Gilbertson","year":"2006","unstructured":"Gilbertson JR, Ho J, Anthony L, Jukic DM, Yagi Y, Parwani AV (2006) Primary histologic diagnosis using automated whole slide imaging: a validation study. BMC Clin Pathol 6:4. https:\/\/doi.org\/10.1186\/1472-6890-6-4","journal-title":"BMC Clin Pathol"},{"issue":"3","key":"6243_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2478\/v10042-009-0087-y","volume":"47","author":"K Kayser","year":"2009","unstructured":"Kayser K, Gortler J, Bogovac M, Bogovac A, Goldmann T, Vollmer E, Kayser G (2009) AI (artificial intelligence) in histopathology\u2013from image analysis to automated diagnosis. Folia Histochem Cytobiol 47(3):355\u2013361. https:\/\/doi.org\/10.2478\/v10042-009-0087-y","journal-title":"Folia Histochem Cytobiol"},{"issue":"1","key":"6243_CR16","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1038\/s41598-018-21758-3","volume":"8","author":"D Bychkov","year":"2018","unstructured":"Bychkov D, Linder N, Turkki R, Nordling S, Kovanen PE, Verrill C, Walliander M, Lundin M, Haglund C, Lundin J (2018) Deep learning based tissue analysis predicts outcome in colorectal cancer. Sci Rep 8(1):3395. https:\/\/doi.org\/10.1038\/s41598-018-21758-3","journal-title":"Sci Rep"},{"issue":"1","key":"6243_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13058-019-1165-5","volume":"21","author":"S Klimov","year":"2019","unstructured":"Klimov S, Miligy IM, Gertych A, Jiang Y, Toss MS, Rida P, Ellis IO, Green A, Krishnamurti U, Rakha EA, Aneja R (2019) A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk. Breast Cancer Res 21(1):83. https:\/\/doi.org\/10.1186\/s13058-019-1165-5","journal-title":"Breast Cancer Res"},{"issue":"10","key":"6243_CR18","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/s41591-018-0177-5","volume":"24","author":"N Coudray","year":"2018","unstructured":"Coudray N, Ocampo PS, Sakellaropoulos T, Narula N, Snuderl M, Fenyo D, Moreira AL, Razavian N, Tsirigos A (2018) Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning. Nat Med 24(10):1559\u20131567. https:\/\/doi.org\/10.1038\/s41591-018-0177-5","journal-title":"Nat Med"},{"issue":"12","key":"6243_CR19","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/modpathol.2012.126","volume":"25","author":"M Veta","year":"2012","unstructured":"Veta M, Kornegoor R, Huisman A, Verschuur-Maes AH, Viergever MA, Pluim JP, van Diest PJ (2012) Prognostic value of automatically extracted nuclear morphometric features in whole slide images of male breast cancer. Mod Pathol 25(12):1559\u20131565. https:\/\/doi.org\/10.1038\/modpathol.2012.126","journal-title":"Mod Pathol"},{"issue":"5","key":"6243_CR20","doi-asserted-by":"publisher","first-page":"e97954","DOI":"10.1371\/journal.pone.0097954","volume":"9","author":"G Lee","year":"2014","unstructured":"Lee G, Sparks R, Ali S, Shih NN, Feldman MD, Spangler E, Rebbeck T, Tomaszewski JE, Madabhushi A (2014) Co-occurring gland angularity in localized subgraphs: predicting biochemical recurrence in intermediate-risk prostate cancer patients. PLoS ONE 9(5):e97954. https:\/\/doi.org\/10.1371\/journal.pone.0097954","journal-title":"PLoS ONE"},{"issue":"8","key":"6243_CR21","doi-asserted-by":"publisher","first-page":"e198777","DOI":"10.1001\/jamanetworkopen.2019.8777","volume":"2","author":"E Mercan","year":"2019","unstructured":"Mercan E, Mehta S, Bartlett J, Shapiro LG, Weaver DL, Elmore JG (2019) Assessment of machine learning of breast pathology structures for automated differentiation of breast cancer and high-risk proliferative lesions. JAMA Netw Open 2(8):e198777. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.8777","journal-title":"JAMA Netw Open"},{"issue":"Suppl 3","key":"6243_CR22","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.2188\/jea.JE20170249","volume":"28","author":"T Nakamura","year":"2018","unstructured":"Nakamura T, Nakamura Y, Saitoh S, Okamura T, Yanagita M, Yoshita K, Kita Y, Murakami Y, Yokomichi H, Nishi N, Okuda N, Kadota A, Ohkubo T, Ueshima H, Okayama A, Miura K (2018) Relationship between socioeconomic status and the prevalence of underweight, overweight or obesity in a general Japanese population: NIPPON DATA2010. J Epidemiol 28(Suppl 3):S10\u2013S16. https:\/\/doi.org\/10.2188\/jea.JE20170249","journal-title":"J Epidemiol"},{"key":"6243_CR23","doi-asserted-by":"crossref","unstructured":"Szegedy C, Vanhoucke V, Ioffe S, Shlens J, Wojna Z (2015) Rethinking the inception architecture for computer vision. arXiv preprint arXiv 1512:00567","DOI":"10.1109\/CVPR.2016.308"},{"issue":"21","key":"6243_CR24","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1200\/JCO.2006.06.1366","volume":"24","author":"N Bijker","year":"2006","unstructured":"Group EBCC, Group ER, Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, Gennaro M, Rouanet P, Avril A, Fentiman IS, Bartelink H, Rutgers EJ (2006) Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853\u2014A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24(21):3381\u20133387. https:\/\/doi.org\/10.1200\/JCO.2006.06.1366","journal-title":"J Clin Oncol"},{"issue":"8","key":"6243_CR25","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1002\/(SICI)1097-0142(20000415)88:8<1976::AID-CNCR29>3.0.CO;2-P","volume":"88","author":"B Cutuli","year":"2000","unstructured":"Cutuli B (2000) Pathologic findings from the national surgical adjuvant breast project (NSABP) eight-year update of protocol B-17: intraductal carcinoma. Cancer 88(8):1976\u20131977","journal-title":"Cancer"},{"issue":"12","key":"6243_CR26","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/s41416-018-0337-x","volume":"119","author":"MS Toss","year":"2018","unstructured":"Toss MS, Miligy IM, Gorringe KL, AlKawaz A, Khout H, Ellis IO, Green AR, Rakha EA (2018) Prolyl-4-hydroxylase Alpha subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS). Br J Cancer 119(12):1518\u20131526. https:\/\/doi.org\/10.1038\/s41416-018-0337-x","journal-title":"Br J Cancer"},{"issue":"1","key":"6243_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10549-019-05459-7","volume":"179","author":"AI Aljohani","year":"2020","unstructured":"Aljohani AI, Toss MS, Kurozumi S, Joseph C, Aleskandarany MA, Miligy IM, Ansari RE, Mongan NP, Ellis IO, Green AR, Rakha EA (2020) The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer. Breast Cancer Res Treat 179(1):79\u201390. https:\/\/doi.org\/10.1007\/s10549-019-05459-7","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"6243_CR28","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2072::AID-CNCR13>3.0.CO;2-H","volume":"88","author":"F Moinfar","year":"2000","unstructured":"Moinfar F, Man YG, Bratthauer GL, Ratschek M, Tavassoli FA (2000) Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type (\u201cclinging ductal carcinoma in situ\u201d): a simulator of normal mammary epithelium. Cancer 88(9):2072\u20132081","journal-title":"Cancer"},{"issue":"6","key":"6243_CR29","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jamcollsurg.2017.08.022","volume":"225","author":"LR Lamb","year":"2017","unstructured":"Lamb LR, Bahl M, Gadd MA, Lehman CD (2017) Flat epithelial atypia: upgrade rates and risk-stratification approach to support informed decision making. J Am Coll Surg 225(6):696\u2013701. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2017.08.022","journal-title":"J Am Coll Surg"},{"issue":"8","key":"6243_CR30","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.arcmed.2020.09.011","volume":"51","author":"I Alvarado-Cabrero","year":"2020","unstructured":"Alvarado-Cabrero I, Valencia-Cedillo R, Estevez-Castro R (2020) Preneoplasia of the Breast and Molecular Landscape. Arch Med Res 51(8):845\u2013850. https:\/\/doi.org\/10.1016\/j.arcmed.2020.09.011","journal-title":"Arch Med Res"},{"issue":"3","key":"6243_CR31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/modpathol.3800538","volume":"19","author":"DJ Dabbs","year":"2006","unstructured":"Dabbs DJ, Carter G, Fudge M, Peng Y, Swalsky P, Finkelstein S (2006) Molecular alterations in columnar cell lesions of the breast. Mod Pathol 19(3):344\u2013349. https:\/\/doi.org\/10.1038\/modpathol.3800538","journal-title":"Mod Pathol"},{"issue":"7","key":"6243_CR32","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/modpathol.2012.55","volume":"25","author":"ML Troxell","year":"2012","unstructured":"Troxell ML, Brunner AL, Neff T, Warrick A, Beadling C, Montgomery K, Zhu S, Corless CL, West RB (2012) Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions. Mod Pathol 25(7):930\u2013937. https:\/\/doi.org\/10.1038\/modpathol.2012.55","journal-title":"Mod Pathol"},{"issue":"4","key":"6243_CR33","doi-asserted-by":"publisher","first-page":"928","DOI":"10.2214\/AJR.12.9906","volume":"201","author":"M Seo","year":"2013","unstructured":"Seo M, Chang JM, Kim WH, Park IA, Lee SH, Cho N, Moon WK (2013) Columnar cell lesions without atypia initially diagnosed on breast needle biopsies: is imaging follow-up enough? AJR Am J Roentgenol 201(4):928\u2013934. https:\/\/doi.org\/10.2214\/AJR.12.9906","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"6243_CR34","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/PAS.0000000000001385","volume":"44","author":"A Grabenstetter","year":"2020","unstructured":"Grabenstetter A, Brennan S, Salagean ED, Morrow M, Brogi E (2020) Flat epithelial atypia in breast core needle biopsies with radiologic-pathologic concordance: is excision necessary? Am J Surg Pathol 44(2):182\u2013190. https:\/\/doi.org\/10.1097\/PAS.0000000000001385","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"6243_CR35","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/0003134820943546","volume":"86","author":"JL Miller-Ocuin","year":"2020","unstructured":"Miller-Ocuin JL, Fowler BB, Coldren DL, Chiba A, Levine EA, Howard-McNatt M (2020) Is excisional biopsy needed for pure FEA diagnosed on a core biopsy? Am Surg 86(9):1088\u20131090. https:\/\/doi.org\/10.1177\/0003134820943546","journal-title":"Am Surg"},{"issue":"3","key":"6243_CR36","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1046\/j.1365-2559.2000.00882.x","volume":"37","author":"F Otterbach","year":"2000","unstructured":"Otterbach F, Bankfalvi A, Bergner S, Decker T, Krech R, Boecker W (2000) Cytokeratin 5\/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology 37(3):232\u2013240. https:\/\/doi.org\/10.1046\/j.1365-2559.2000.00882.x","journal-title":"Histopathology"},{"issue":"6","key":"6243_CR37","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1365-2559.2008.03016.x","volume":"52","author":"G MacGrogan","year":"2008","unstructured":"MacGrogan G, Arnould L, de Mascarel I, Vincent-Salomon A, Penault-Llorca F, Lacroix-Triki M, Bibeau F, Baranzelli MC, Fridman V, Antoine M, Becette V, Brouste V, Jacquemier J, Mathoulin-Pelissier S, Group G (2008) Impact of immunohistochemical markers, CK5\/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions. Histopathology 52(6):689\u2013697. https:\/\/doi.org\/10.1111\/j.1365-2559.2008.03016.x","journal-title":"Histopathology"},{"issue":"4","key":"6243_CR38","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10278-019-00182-7","volume":"32","author":"MZ Alom","year":"2019","unstructured":"Alom MZ, Yakopcic C, Nasrin MS, Taha TM, Asari VK (2019) Breast cancer classification from histopathological images with inception recurrent residual convolutional neural network. J Digit Imaging 32(4):605\u2013617. https:\/\/doi.org\/10.1007\/s10278-019-00182-7","journal-title":"J Digit Imaging"},{"issue":"4","key":"6243_CR39","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10555-018-9768-3","volume":"37","author":"JM Houthuijzen","year":"2018","unstructured":"Houthuijzen JM, Jonkers J (2018) Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment. Cancer Metastasis Rev 37(4):577\u2013597. https:\/\/doi.org\/10.1007\/s10555-018-9768-3","journal-title":"Cancer Metastasis Rev"},{"issue":"9","key":"6243_CR40","doi-asserted-by":"publisher","first-page":"107701","DOI":"10.1016\/j.celrep.2020.107701","volume":"31","author":"LM Becker","year":"2020","unstructured":"Becker LM, O\u2019Connell JT, Vo AP, Cain MP, Tampe D, Bizarro L, Sugimoto H, McGow AK, Asara JM, Lovisa S, McAndrews KM, Zielinski R, Lorenzi PL, Zeisberg M, Raza S, LeBleu VS, Kalluri R (2020) Epigenetic reprogramming of cancer-associated fibroblasts deregulates glucose metabolism and facilitates progression of breast cancer. Cell Rep 31(9):107701. https:\/\/doi.org\/10.1016\/j.celrep.2020.107701","journal-title":"Cell Rep"},{"issue":"4","key":"6243_CR41","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/pros.20109","volume":"61","author":"D Tomas","year":"2004","unstructured":"Tomas D, Kruslin B (2004) The potential value of (Myo)fibroblastic stromal reaction in the diagnosis of prostatic adenocarcinoma. Prostate 61(4):324\u2013331. https:\/\/doi.org\/10.1002\/pros.20109","journal-title":"Prostate"},{"key":"6243_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/1742-6413.189639","volume":"13","author":"KT Mai","year":"2016","unstructured":"Mai KT, Hogan K (2016) Stromal tissue as an adjunct tool in the diagnosis of follicular thyroid lesions by fine-needle aspiration biopsy. Cytojournal 13:20. https:\/\/doi.org\/10.4103\/1742-6413.189639","journal-title":"Cytojournal"},{"issue":"4","key":"6243_CR43","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1309\/B0DD-4M7H-GJG1-7KCW","volume":"115","author":"NS Goldstein","year":"2001","unstructured":"Goldstein NS, Bassi D, Watts JC, Layfield LJ, Yaziji H, Gown AM (2001) E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions. Am J Clin Pathol 115(4):534\u2013542. https:\/\/doi.org\/10.1309\/B0DD-4M7H-GJG1-7KCW","journal-title":"Am J Clin Pathol"},{"key":"6243_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-00689-3","author":"A Sokolova","year":"2020","unstructured":"Sokolova A, Lakhani SR (2020) Lobular carcinoma in situ: diagnostic criteria and molecular correlates. Mod Pathol. https:\/\/doi.org\/10.1038\/s41379-020-00689-3","journal-title":"Mod Pathol"},{"key":"6243_CR45","doi-asserted-by":"publisher","first-page":"45938","DOI":"10.1038\/srep45938","volume":"7","author":"ME Vandenberghe","year":"2017","unstructured":"Vandenberghe ME, Scott ML, Scorer PW, Soderberg M, Balcerzak D, Barker C (2017) Relevance of deep learning to facilitate the diagnosis of HER2 status in breast cancer. Sci Rep 7:45938. https:\/\/doi.org\/10.1038\/srep45938","journal-title":"Sci Rep"},{"issue":"7","key":"6243_CR46","doi-asserted-by":"publisher","first-page":"e197700","DOI":"10.1001\/jamanetworkopen.2019.7700","volume":"2","author":"G Shamai","year":"2019","unstructured":"Shamai G, Binenbaum Y, Slossberg R, Duek I, Gil Z, Kimmel R (2019) Artificial intelligence algorithms to assess hormonal status from tissue microarrays in patients with breast cancer. JAMA Netw Open 2(7):e197700. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.7700","journal-title":"JAMA Netw Open"},{"key":"6243_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/jpi.jpi_10_20","volume":"11","author":"D Anand","year":"2020","unstructured":"Anand D, Kurian NC, Dhage S, Kumar N, Rane S, Gann PH, Sethi A (2020) Deep learning to estimate human epidermal growth factor receptor 2 status from hematoxylin and eosin-stained breast tissue images. J Pathol Inform 11:19. https:\/\/doi.org\/10.4103\/jpi.jpi_10_20","journal-title":"J Pathol Inform"},{"issue":"1","key":"6243_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13000-020-00957-5","volume":"15","author":"M Feng","year":"2020","unstructured":"Feng M, Deng Y, Yang L, Jing Q, Zhang Z, Xu L, Wei X, Zhou Y, Wu D, Xiang F, Wang Y, Bao J, Bu H (2020) Automated quantitative analysis of Ki-67 staining and HE images recognition and registration based on whole tissue sections in breast carcinoma. Diagn Pathol 15(1):65. https:\/\/doi.org\/10.1186\/s13000-020-00957-5","journal-title":"Diagn Pathol"},{"issue":"12","key":"6243_CR49","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1097\/PAS.0000000000001151","volume":"42","author":"DF Steiner","year":"2018","unstructured":"Steiner DF, MacDonald R, Liu Y, Truszkowski P, Hipp JD, Gammage C, Thng F, Peng L, Stumpe MC (2018) Impact of deep learning assistance on the histopathologic review of lymph nodes for metastatic breast cancer. Am J Surg Pathol 42(12):1636\u20131646. https:\/\/doi.org\/10.1097\/PAS.0000000000001151","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"6243_CR50","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/s41379-018-0073-z","volume":"31","author":"B Ehteshami Bejnordi","year":"2018","unstructured":"Ehteshami Bejnordi B, Mullooly M, Pfeiffer RM, Fan S, Vacek PM, Weaver DL, Herschorn S, Brinton LA, van Ginneken B, Karssemeijer N, Beck AH, Gierach GL, van der Laak J, Sherman ME (2018) Using deep convolutional neural networks to identify and classify tumor-associated stroma in diagnostic breast biopsies. Mod Pathol 31(10):1502\u20131512. https:\/\/doi.org\/10.1038\/s41379-018-0073-z","journal-title":"Mod Pathol"},{"issue":"2","key":"6243_CR51","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/PAS.0000000000000949","volume":"42","author":"AM Mills","year":"2018","unstructured":"Mills AM, Dill EA, Moskaluk CA, Dziegielewski J, Bullock TN, Dillon PM (2018) The relationship between mismatch repair deficiency and PD-L1 expression in breast carcinoma. Am J Surg Pathol 42(2):183\u2013191. https:\/\/doi.org\/10.1097\/PAS.0000000000000949","journal-title":"Am J Surg Pathol"},{"issue":"21","key":"6243_CR52","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1200\/JCO.2015.64.8931","volume":"34","author":"R Nanda","year":"2016","unstructured":"Nanda R, Chow LQ, Dees EC, Berger R, Gupta S, Geva R, Pusztai L, Pathiraja K, Aktan G, Cheng JD, Karantza V, Buisseret L (2016) Pembrolizumab in patients with advanced triple-negative breast cancer: phase Ib KEYNOTE-012 study. J Clin Oncol 34(21):2460\u20132467. https:\/\/doi.org\/10.1200\/JCO.2015.64.8931","journal-title":"J Clin Oncol"},{"issue":"3","key":"6243_CR53","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1200\/JCO.18.01624","volume":"37","author":"S Johnston","year":"2019","unstructured":"Johnston S, Puhalla S, Wheatley D, Ring A, Barry P, Holcombe C, Boileau JF, Provencher L, Robidoux A, Rimawi M, McIntosh SA, Shalaby I, Stein RC, Thirlwell M, Dolling D, Morden J, Snowdon C, Perry S, Cornman C, Batten LM, Jeffs LK, Dodson A, Martins V, Modi A, Osborne CK, Pogue-Geile KL, Cheang MCU, Wolmark N, Julian TB, Fisher K, MacKenzie M, Wilcox M, Huang Bartlett C, Koehler M, Dowsett M, Bliss JM, Jacobs SA (2019) Randomized phase II study evaluating palbociclib in addition to letrozole as neoadjuvant therapy in estrogen receptor-positive early breast cancer: PALLET trial. J Clin Oncol 37(3):178\u2013189. https:\/\/doi.org\/10.1200\/JCO.18.01624","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06243-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-021-06243-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06243-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T18:09:50Z","timestamp":1625940590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-021-06243-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["6243"],"URL":"https:\/\/doi.org\/10.1007\/s10549-021-06243-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,1]]},"assertion":[{"value":"5 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Y. Miyagi has consigned a\u00a0research fund from Tosoh Corporation. T. Yamashita has received research grants and\/or honoraria for lecturing from Chugai, Eisai, Novartis Pharma, Taiho, Nippon Kayaku, AstraZeneca, Kyowa Kirin, Pfizer Japan, Eli Lilly, and Daiichi Sankyo. T. Yamanaka has received honoraria for lecturing from Chugai, Eisai, Novartis Pharma, AstraZeneca, Kyowa Kirin, Pfizer Japan, Eli Lilly, and Daiichi Sankyo. No other authors have a\u00a0conflict of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval for this study was sought and granted by the institutional review board of Kanagawa Cancer Center and Chiba University. This article does not contain any new studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}